nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNA4—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0521	0.277	CbGeAlD
Varenicline—CHRNA6—ganglion—peripheral nervous system neoplasm	0.0292	0.155	CbGeAlD
Varenicline—CHRNA4—cochlea—peripheral nervous system neoplasm	0.0264	0.14	CbGeAlD
Varenicline—CHRNA6—brainstem—peripheral nervous system neoplasm	0.0127	0.0674	CbGeAlD
Varenicline—CHRNA7—ganglion—peripheral nervous system neoplasm	0.0106	0.0564	CbGeAlD
Varenicline—CHRNA4—nerve—peripheral nervous system neoplasm	0.0106	0.0564	CbGeAlD
Varenicline—CHRNA4—ganglion—peripheral nervous system neoplasm	0.0105	0.0557	CbGeAlD
Varenicline—CHRNB2—trigeminal ganglion—peripheral nervous system neoplasm	0.00823	0.0438	CbGeAlD
Varenicline—CHRNB2—parotid gland—peripheral nervous system neoplasm	0.00777	0.0413	CbGeAlD
Varenicline—CHRNA6—cerebellum—peripheral nervous system neoplasm	0.00625	0.0332	CbGeAlD
Varenicline—CHRNA4—brainstem—peripheral nervous system neoplasm	0.00455	0.0242	CbGeAlD
Varenicline—CHRNB2—cerebellum—peripheral nervous system neoplasm	0.00359	0.0191	CbGeAlD
Varenicline—CHRNA3—cerebellum—peripheral nervous system neoplasm	0.00348	0.0185	CbGeAlD
Varenicline—CHRNA4—cerebellum—peripheral nervous system neoplasm	0.00225	0.0119	CbGeAlD
Varenicline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000347	0.000428	CcSEcCtD
Varenicline—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000426	CcSEcCtD
Varenicline—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000425	CcSEcCtD
Varenicline—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000425	CcSEcCtD
Varenicline—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000422	CcSEcCtD
Varenicline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000342	0.000422	CcSEcCtD
Varenicline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000341	0.00042	CcSEcCtD
Varenicline—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000419	CcSEcCtD
Varenicline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000339	0.000418	CcSEcCtD
Varenicline—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000339	0.000417	CcSEcCtD
Varenicline—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000417	CcSEcCtD
Varenicline—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000338	0.000417	CcSEcCtD
Varenicline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000336	0.000413	CcSEcCtD
Varenicline—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000413	CcSEcCtD
Varenicline—Pain—Cisplatin—peripheral nervous system neoplasm	0.000335	0.000413	CcSEcCtD
Varenicline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.000407	CcSEcCtD
Varenicline—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000406	CcSEcCtD
Varenicline—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000403	CcSEcCtD
Varenicline—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000403	CcSEcCtD
Varenicline—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000403	CcSEcCtD
Varenicline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000327	0.000402	CcSEcCtD
Varenicline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.000401	CcSEcCtD
Varenicline—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000398	CcSEcCtD
Varenicline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000323	0.000398	CcSEcCtD
Varenicline—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000397	CcSEcCtD
Varenicline—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00032	0.000394	CcSEcCtD
Varenicline—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000393	CcSEcCtD
Varenicline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000319	0.000393	CcSEcCtD
Varenicline—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000393	CcSEcCtD
Varenicline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000318	0.000392	CcSEcCtD
Varenicline—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000389	CcSEcCtD
Varenicline—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000389	CcSEcCtD
Varenicline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.000389	CcSEcCtD
Varenicline—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000388	CcSEcCtD
Varenicline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000315	0.000388	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000385	CcSEcCtD
Varenicline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000313	0.000385	CcSEcCtD
Varenicline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000312	0.000385	CcSEcCtD
Varenicline—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00031	0.000382	CcSEcCtD
Varenicline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00031	0.000382	CcSEcCtD
Varenicline—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00031	0.000381	CcSEcCtD
Varenicline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000379	CcSEcCtD
Varenicline—Pain—Etoposide—peripheral nervous system neoplasm	0.000307	0.000378	CcSEcCtD
Varenicline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000307	0.000378	CcSEcCtD
Varenicline—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000378	CcSEcCtD
Varenicline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.000375	CcSEcCtD
Varenicline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000303	0.000374	CcSEcCtD
Varenicline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000373	CcSEcCtD
Varenicline—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000368	CcSEcCtD
Varenicline—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000368	CcSEcCtD
Varenicline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000367	CcSEcCtD
Varenicline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000367	CcSEcCtD
Varenicline—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000365	CcSEcCtD
Varenicline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000296	0.000365	CcSEcCtD
Varenicline—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000364	CcSEcCtD
Varenicline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000295	0.000363	CcSEcCtD
Varenicline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000294	0.000362	CcSEcCtD
Varenicline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000293	0.000361	CcSEcCtD
Varenicline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.00036	CcSEcCtD
Varenicline—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00036	CcSEcCtD
Varenicline—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00036	CcSEcCtD
Varenicline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.000357	CcSEcCtD
Varenicline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.000357	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000357	CcSEcCtD
Varenicline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000289	0.000356	CcSEcCtD
Varenicline—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000355	CcSEcCtD
Varenicline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.000355	CcSEcCtD
Varenicline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000285	0.000351	CcSEcCtD
Varenicline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000351	CcSEcCtD
Varenicline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000284	0.00035	CcSEcCtD
Varenicline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000284	0.00035	CcSEcCtD
Varenicline—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00035	CcSEcCtD
Varenicline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000347	CcSEcCtD
Varenicline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000282	0.000347	CcSEcCtD
Varenicline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000281	0.000346	CcSEcCtD
Varenicline—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000345	CcSEcCtD
Varenicline—Rash—Vincristine—peripheral nervous system neoplasm	0.00028	0.000344	CcSEcCtD
Varenicline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000279	0.000344	CcSEcCtD
Varenicline—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000279	0.000344	CcSEcCtD
Varenicline—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000343	CcSEcCtD
Varenicline—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000342	CcSEcCtD
Varenicline—Headache—Vincristine—peripheral nervous system neoplasm	0.000278	0.000342	CcSEcCtD
Varenicline—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.00034	CcSEcCtD
Varenicline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000339	CcSEcCtD
Varenicline—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000337	CcSEcCtD
Varenicline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.000337	CcSEcCtD
Varenicline—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000336	CcSEcCtD
Varenicline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000268	0.00033	CcSEcCtD
Varenicline—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00033	CcSEcCtD
Varenicline—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000329	CcSEcCtD
Varenicline—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000326	CcSEcCtD
Varenicline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000265	0.000326	CcSEcCtD
Varenicline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000325	CcSEcCtD
Varenicline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000263	0.000324	CcSEcCtD
Varenicline—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000324	CcSEcCtD
Varenicline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000321	CcSEcCtD
Varenicline—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000319	CcSEcCtD
Varenicline—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000318	CcSEcCtD
Varenicline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000258	0.000317	CcSEcCtD
Varenicline—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000317	CcSEcCtD
Varenicline—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000317	CcSEcCtD
Varenicline—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000317	CcSEcCtD
Varenicline—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000315	CcSEcCtD
Varenicline—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000315	CcSEcCtD
Varenicline—Chills—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000313	CcSEcCtD
Varenicline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000254	0.000313	CcSEcCtD
Varenicline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000312	CcSEcCtD
Varenicline—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000311	CcSEcCtD
Varenicline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000249	0.000307	CcSEcCtD
Varenicline—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000306	CcSEcCtD
Varenicline—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000305	CcSEcCtD
Varenicline—Rash—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000304	CcSEcCtD
Varenicline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000304	CcSEcCtD
Varenicline—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000304	CcSEcCtD
Varenicline—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000304	CcSEcCtD
Varenicline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000246	0.000303	CcSEcCtD
Varenicline—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000302	CcSEcCtD
Varenicline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000301	CcSEcCtD
Varenicline—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.0003	CcSEcCtD
Varenicline—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000299	CcSEcCtD
Varenicline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000298	CcSEcCtD
Varenicline—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000294	CcSEcCtD
Varenicline—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000293	CcSEcCtD
Varenicline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000237	0.000293	CcSEcCtD
Varenicline—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000292	CcSEcCtD
Varenicline—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000292	CcSEcCtD
Varenicline—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000291	CcSEcCtD
Varenicline—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00029	CcSEcCtD
Varenicline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000288	CcSEcCtD
Varenicline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000233	0.000287	CcSEcCtD
Varenicline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000286	CcSEcCtD
Varenicline—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000283	CcSEcCtD
Varenicline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000282	CcSEcCtD
Varenicline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000228	0.000281	CcSEcCtD
Varenicline—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000281	CcSEcCtD
Varenicline—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000281	CcSEcCtD
Varenicline—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000281	CcSEcCtD
Varenicline—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000279	CcSEcCtD
Varenicline—Rash—Etoposide—peripheral nervous system neoplasm	0.000226	0.000279	CcSEcCtD
Varenicline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000226	0.000279	CcSEcCtD
Varenicline—Headache—Etoposide—peripheral nervous system neoplasm	0.000225	0.000277	CcSEcCtD
Varenicline—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000277	CcSEcCtD
Varenicline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000275	CcSEcCtD
Varenicline—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000274	CcSEcCtD
Varenicline—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000273	CcSEcCtD
Varenicline—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000272	CcSEcCtD
Varenicline—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000272	CcSEcCtD
Varenicline—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00027	CcSEcCtD
Varenicline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000268	CcSEcCtD
Varenicline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000267	CcSEcCtD
Varenicline—Cough—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000265	CcSEcCtD
Varenicline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000265	CcSEcCtD
Varenicline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000263	CcSEcCtD
Varenicline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000213	0.000263	CcSEcCtD
Varenicline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000262	CcSEcCtD
Varenicline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000261	CcSEcCtD
Varenicline—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00026	CcSEcCtD
Varenicline—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000259	CcSEcCtD
Varenicline—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000259	CcSEcCtD
Varenicline—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000259	CcSEcCtD
Varenicline—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000258	CcSEcCtD
Varenicline—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000258	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000257	CcSEcCtD
Varenicline—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000256	CcSEcCtD
Varenicline—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000253	CcSEcCtD
Varenicline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000253	CcSEcCtD
Varenicline—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000253	CcSEcCtD
Varenicline—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000252	CcSEcCtD
Varenicline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000248	CcSEcCtD
Varenicline—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000248	CcSEcCtD
Varenicline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000247	CcSEcCtD
Varenicline—Infection—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000246	CcSEcCtD
Varenicline—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000245	CcSEcCtD
Varenicline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000244	CcSEcCtD
Varenicline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000244	CcSEcCtD
Varenicline—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000243	CcSEcCtD
Varenicline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000243	CcSEcCtD
Varenicline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000243	CcSEcCtD
Varenicline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000242	CcSEcCtD
Varenicline—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000241	CcSEcCtD
Varenicline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00024	CcSEcCtD
Varenicline—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000239	CcSEcCtD
Varenicline—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000239	CcSEcCtD
Varenicline—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000239	CcSEcCtD
Varenicline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000238	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000238	CcSEcCtD
Varenicline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000236	CcSEcCtD
Varenicline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000236	CcSEcCtD
Varenicline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000234	CcSEcCtD
Varenicline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000232	CcSEcCtD
Varenicline—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000229	CcSEcCtD
Varenicline—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000228	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000226	CcSEcCtD
Varenicline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000226	CcSEcCtD
Varenicline—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000225	CcSEcCtD
Varenicline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000225	CcSEcCtD
Varenicline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000224	CcSEcCtD
Varenicline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000224	CcSEcCtD
Varenicline—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000223	CcSEcCtD
Varenicline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000222	CcSEcCtD
Varenicline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000221	CcSEcCtD
Varenicline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00022	CcSEcCtD
Varenicline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000219	CcSEcCtD
Varenicline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000218	CcSEcCtD
Varenicline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000216	CcSEcCtD
Varenicline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000214	CcSEcCtD
Varenicline—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000214	CcSEcCtD
Varenicline—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000214	CcSEcCtD
Varenicline—Pain—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000212	CcSEcCtD
Varenicline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000212	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000209	CcSEcCtD
Varenicline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000208	CcSEcCtD
Varenicline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000205	CcSEcCtD
Varenicline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000204	CcSEcCtD
Varenicline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000204	CcSEcCtD
Varenicline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000203	CcSEcCtD
Varenicline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000202	CcSEcCtD
Varenicline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000199	CcSEcCtD
Varenicline—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000198	CcSEcCtD
Varenicline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000198	CcSEcCtD
Varenicline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000197	CcSEcCtD
Varenicline—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000196	CcSEcCtD
Varenicline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000196	CcSEcCtD
Varenicline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000196	CcSEcCtD
Varenicline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000196	CcSEcCtD
Varenicline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000189	CcSEcCtD
Varenicline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000188	CcSEcCtD
Varenicline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000183	CcSEcCtD
Varenicline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000182	CcSEcCtD
Varenicline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000181	CcSEcCtD
Varenicline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000181	CcSEcCtD
Varenicline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000178	CcSEcCtD
Varenicline—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000175	CcSEcCtD
Varenicline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00017	CcSEcCtD
Varenicline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000169	CcSEcCtD
Varenicline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000165	CcSEcCtD
Varenicline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000164	CcSEcCtD
Varenicline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000162	CcSEcCtD
Varenicline—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000158	CcSEcCtD
Varenicline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000157	CcSEcCtD
Varenicline—Rash—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000156	CcSEcCtD
Varenicline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000156	CcSEcCtD
Varenicline—Headache—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000155	CcSEcCtD
Varenicline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000152	CcSEcCtD
Varenicline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000147	CcSEcCtD
Varenicline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000146	CcSEcCtD
Varenicline—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000145	CcSEcCtD
Varenicline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000145	CcSEcCtD
Varenicline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000144	CcSEcCtD
Varenicline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000136	CcSEcCtD
